GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Global Health Clinics Ltd (XCNQ:MJRX) » Definitions » Beta

Global Health Clinics (XCNQ:MJRX) Beta : 1.08 (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Global Health Clinics Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-21), Global Health Clinics's Beta is 1.08.


Global Health Clinics Beta Historical Data

The historical data trend for Global Health Clinics's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health Clinics Beta Chart

Global Health Clinics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.06 1.70 2.92 2.93 4.03

Global Health Clinics Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.91 4.21 4.03 3.73 2.10

Competitive Comparison of Global Health Clinics's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Global Health Clinics's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Health Clinics's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Global Health Clinics's Beta distribution charts can be found below:

* The bar in red indicates where Global Health Clinics's Beta falls into.



Global Health Clinics Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Global Health Clinics  (XCNQ:MJRX) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Global Health Clinics Beta Related Terms

Thank you for viewing the detailed overview of Global Health Clinics's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Health Clinics (XCNQ:MJRX) Business Description

Traded in Other Exchanges
Address
837 West Hastings Street, Suite 400, Vancouver, BC, CAN, V6C 3N6
Global Health Clinics Ltd engages in the cannabis industry and operates medical clinics which guide patients through the process of becoming legal users of marijuana and also engages in developing psilocybin products for research and their potential usage for pharmaceutical purposes. The Company operates in two operating segments the operating of medical clinics to guide patients to become legal users of marijuana and the development of psilocybin products for research and potential usage for pharmaceutical purposes. The Company derives its key revenue from Medical Clinics for legal user of Marijuana.

Global Health Clinics (XCNQ:MJRX) Headlines

No Headlines